2nd Quarter - Report

WILLIAMS AND JENSEN, PLLC for GENENTECH INC

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

General tax issues.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER —
KARINA LYNCH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Payment policies for prescription drugs.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 7; Sr Policy Adv, Majority Leader, Rep Eric Cantor; Sr Policy Adv, Republican Whip, Rep Eric Cantor; Sr Policy Adv, Majority Whip, Rep. Roy Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C Cox
KARINA LYNCH —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

General education about policies impacting pharmaceutical development, approval and reimbursement; H.R. 1628 American Health Care Act of 2017; Better Care Reconciliation Act; S. 934, H.R. 2430, FDA Reauthorization Act of 2017; general education about FDA approval policies; S. 204, Trickett Wendler Right to Try Act; H.R. 878, Right to Try Act of 2017.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER —
KARINA LYNCH —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 934 (115th), S. 204 (115th), H.R. 1628 (115th), H.R. 2430 (115th), H.R. 878 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.